SIBN
Si-Bone Inc
NASDAQ: SIBN · HEALTHCARE · MEDICAL DEVICES
$12.39
+3.86% today
Updated 2026-04-30
Market cap
$546.85M
P/E ratio
—
P/S ratio
2.72x
EPS (TTM)
$-0.44
Dividend yield
—
52W range
$12 – $22
Volume
0.6M
Si-Bone Inc (SIBN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37.02M | $49.00M | $40.05M | $41.17M | $42.10M | $47.98M | $55.38M | $67.30M | $73.39M | $90.15M | $106.41M | $138.89M | $167.18M | $200.93M |
| Revenue growth (YoY) | — | +32.4% | -18.3% | +2.8% | +2.3% | +14.0% | +15.4% | +21.5% | +9.0% | +22.8% | +18.0% | +30.5% | +20.4% | +20.2% |
| Cost of revenue | $3.04M | $4.33M | $6.50M | $5.40M | $5.17M | $5.11M | $4.83M | $6.79M | $8.90M | $10.43M | $15.71M | $29.47M | $35.06M | $41.05M |
| Gross profit | $33.98M | $44.67M | $33.55M | $35.77M | $36.94M | $42.87M | $50.55M | $60.51M | $64.48M | $79.72M | $90.70M | $109.42M | $132.12M | $159.88M |
| Gross margin | 91.8% | 91.2% | 83.8% | 86.9% | 87.7% | 89.3% | 91.3% | 89.9% | 87.9% | 88.4% | 85.2% | 78.8% | 79.0% | 79.6% |
| R&D | $3.77M | $8.37M | $9.17M | $8.61M | $6.38M | $5.51M | $5.38M | $7.28M | $9.46M | $12.44M | $13.63M | $15.03M | $16.56M | $17.45M |
| SG&A | $5.23M | $6.85M | $10.06M | $13.79M | $12.91M | $13.06M | $12.64M | $20.98M | $19.80M | $25.07M | $28.96M | $31.07M | $33.76M | $40.54M |
| Operating income | $-10.72M | $-5.30M | $-26.30M | $-26.42M | $-17.57M | $-17.35M | $-11.96M | $-36.00M | $-38.57M | $-51.67M | $-59.61M | $-46.93M | $-35.25M | $-22.33M |
| Operating margin | -29.0% | -10.8% | -65.7% | -64.2% | -41.7% | -36.2% | -21.6% | -53.5% | -52.6% | -57.3% | -56.0% | -33.8% | -21.1% | -11.1% |
| EBITDA | $-10.68M | $-5.25M | $-26.01M | $-25.68M | $-16.24M | $-15.82M | $-11.24M | $-32.68M | $-36.47M | $-50.97M | $-54.98M | $-34.45M | $-23.09M | $-10.91M |
| EBITDA margin | -28.8% | -10.7% | -64.9% | -62.4% | -38.6% | -33.0% | -20.3% | -48.6% | -49.7% | -56.5% | -51.7% | -24.8% | -13.8% | -5.4% |
| EBIT | $-10.72M | $-5.30M | $-26.30M | $-26.47M | $-17.28M | $-16.84M | $-11.96M | $-33.45M | $-37.60M | $-53.05M | $-58.44M | $-39.87M | $-27.47M | $-13.63M |
| Interest expense | — | — | $0.00 | $0.00 | $3.31M | $6.20M | $5.49M | $4.95M | $6.10M | $5.37M | $2.82M | $3.46M | $3.44M | $5.28M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-10.90M | $-6.15M | $-27.81M | $-28.15M | $-20.59M | $-23.04M | $-17.45M | $-38.40M | $-43.70M | $-56.57M | $-61.26M | $-43.34M | $-30.91M | $-18.91M |
| Net income growth (YoY) | — | +43.6% | -351.8% | -1.3% | +26.9% | -11.9% | +24.2% | -120.0% | -13.8% | -29.5% | -8.3% | +29.3% | +28.7% | +38.8% |
| Profit margin | -29.5% | -12.6% | -69.4% | -68.4% | -48.9% | -48.0% | -31.5% | -57.1% | -59.5% | -62.8% | -57.6% | -31.2% | -18.5% | -9.4% |